Development of a capitation scale for IDF career soldiers in Israel
Author
Abstract
Suggested Citation
Download full text from publisher
As the access to this document is restricted, you may want to
for a different version of it.References listed on IDEAS
- Gross, Revital & Rosen, Bruce & Shirom, Arie, 2001. "Reforming the Israeli health system: findings of a 3-year evaluation," Health Policy, Elsevier, vol. 56(1), pages 1-20, April.
- Alan, Sule & Crossley, Thomas F. & Grootendorst, Paul & Veall, Michael R., 2002.
"The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada,"
Journal of Health Economics, Elsevier, vol. 21(5), pages 805-826, September.
- Thomas F. Crossley & Paul Grootendorst & Sule Korkmaz & Michael R. Veall, 2000. "The Effects of Drug Subsidies on Out-of Pocket Prescription Drug Expenditures by Seniors: Regional Evidence from Canada," Quantitative Studies in Economics and Population Research Reports 350, McMaster University.
- Thomas F. Crossley & Paul Grootendorst & Sule Kokkmaz & Michael R. Veall, 2000. "The Effects of Drug Subsidies on Out-of-Poket Prescription Drug Expenditures by seniors: regional Evidence from Canada," CEPR Discussion Papers 422, Centre for Economic Policy Research, Research School of Economics, Australian National University.
- Thomas F. Crossley & Paul Grootendorst & Sule Korkmaz & Michael R. Veall, 2000. "The Effects of Drug Subsidies on Out-of Pocket Prescription Drug Expenditures by Seniors: Regional Evidence from Canada," Social and Economic Dimensions of an Aging Population Research Papers 19, McMaster University.
- Hyehoon Lee, "undated". "The Effect of Health Insurance on Health Care Utilization," Discussion Papers in Public Sector Economics 95/3, Division of Economics, School of Business, University of Leicester.
- Shmueli, Amir & Chernichovsky, Dov & Zmora, Irit, 2003. "Risk adjustment and risk sharing: the Israeli experience," Health Policy, Elsevier, vol. 65(1), pages 37-48, July.
- C. J. A. Van Vliet Rene, 2001. "Effects of price and deductibles on medical care demand, estimated from survey data," Applied Economics, Taylor & Francis Journals, vol. 33(12), pages 1515-1524.
- Jeremiah Hurley & Nancy Arbuthnot Johnson, 1991. "The Effects of Co-payments within Drug Reimbursement Programs," Canadian Public Policy, University of Toronto Press, vol. 17(4), pages 473-489, December.
- Zweifel, Peter & Crivelli, Luca, 1996. "Price Regulation of Drugs: Lessons from Germany," Journal of Regulatory Economics, Springer, vol. 10(3), pages 257-273, November.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Lopez-Casasnovas, Guillem & Puig-Junoy, Jaume, 2000.
"Review of the literature on reference pricing,"
Health Policy, Elsevier, vol. 54(2), pages 87-123, November.
- Guillem López & Jaume Puig, 1999. "Review of the literature on reference pricing," Working Papers, Research Center on Health and Economics 362, Department of Economics and Business, Universitat Pompeu Fabra.
- Guillem López & Jaume Puig, 1999. "Review of the literature on reference pricing," Economics Working Papers 362, Department of Economics and Business, Universitat Pompeu Fabra.
- Sam Caldbick & Xiaojing Wu & Tom Lynch & Naser Al-Khatib & Mustafa Andkhoie & Marwa Farag, 2015. "The financial burden of out of pocket prescription drug expenses in Canada," International Journal of Health Economics and Management, Springer, vol. 15(3), pages 329-338, September.
- Horev, Tuvia & Babad, Yair M., 2005. "Healthcare reform implementation: stakeholders and their roles--the Israeli experience," Health Policy, Elsevier, vol. 71(1), pages 1-21, January.
- Lundberg, Lena & Johannesson, Magnus & Isacson, Dag G. L. & Borgquist, Lars, 1998. "Effects of user charges on the use of prescription medicines in different socio-economic groups," Health Policy, Elsevier, vol. 44(2), pages 123-134, May.
- Chiara Bonassi & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni & Nicola Carmine Salerno, 2007. "Il prezzo di riferimento nel quadro regolatorio del mercato farmaceutico," Working Papers CERM 04-2007, Competitività, Regole, Mercati (CERM).
- Ismail Saglam, 2023.
"Incentives of a monopolist for innovation under regulatory threat,"
Economics of Governance, Springer, vol. 24(1), pages 41-66, March.
- Saglam, Ismail, 2022. "Incentives of a Monopolist for Innovation under Regulatory Threat," MPRA Paper 113155, University Library of Munich, Germany.
- Paul V. Grootendorst & Michael R. Veall, 2005.
"National Catastrophic Drug Insurance Revisited: Who Would Benefit from Senator Kirby's Recommendations?,"
Canadian Public Policy, University of Toronto Press, vol. 31(4), pages 341-358, December.
- Thomas F. Crossley & Paul V. Grootendorst & Michael R. Veall, 2003. "National Catastrophic Drug Insurance Revisited: Who Would Benefit from Senator Kirby's Recommendations?," Social and Economic Dimensions of an Aging Population Research Papers 105, McMaster University.
- Thomas F. Crossley & Paul V. Grootendorst & Michael R. Veall, 2003. "National Catastrophic Drug Insurance Revisited: Who Would Benefit from Senator Kirby's Recommendations?," Quantitative Studies in Economics and Population Research Reports 385, McMaster University.
- Lubetzky, Hasia & Friger, Michael & Warshawsky-Livne, Lora & Shvarts, Shifra, 2011. "Distance and socioeconomic status as a health service predictor on the periphery in the southern region of Israel," Health Policy, Elsevier, vol. 100(2), pages 310-316.
- עמיר שמואלי & זק בנדלק ולאה אחדות, 2005. "מי עובר בין קופות חולים בישראל (באנגלית)?," Working Papers 281, National Insurance Institute of Israel.
- Manuel García-Goñi & Pere Ibern & José Inoriza, 2009.
"Hybrid risk adjustment for pharmaceutical benefits,"
The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 10(3), pages 299-308, July.
- Manuel García-Goñi & Pere Ibern & José María Inoriza, 2009. "Hybrid risk adjustment for pharmaceutical benefits," Economics Working Papers 1139, Department of Economics and Business, Universitat Pompeu Fabra.
- Antonio Cabrales, 2003.
"Pharmaceutical generics, vertical product differentiation and public policy,"
Economics Working Papers
662, Department of Economics and Business, Universitat Pompeu Fabra.
- Antonio Cabrales, 2015. "Pharmaceutical Generics, Vertical Product Differentiation, and Public Policy," Working Papers 54, Barcelona School of Economics.
- Antonio Cabrales, 2003. "Pharmaceutical generics, vertical product differentiation and public policy," Working Papers, Research Center on Health and Economics 662, Department of Economics and Business, Universitat Pompeu Fabra.
- Burcay Erus & Nazli Aktakke, 2012.
"Impact of healthcare reforms on out-of-pocket health expenditures in Turkey for public insurees,"
The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(3), pages 337-346, June.
- Burçay Erus, 2010. "Impact of Healthcare Reforms on Out-of-Pocket Health Expenditures in Turkey for Public Insurees," Working Papers 544, Economic Research Forum, revised 09 Jan 2010.
- Brekke, Kurt R. & Grasdal, Astrid L. & Holms, Tor Helge, 2009.
"Regulation and pricing of pharmaceuticals: Reference pricing or price cap regulation?,"
European Economic Review, Elsevier, vol. 53(2), pages 170-185, February.
- Brekke, Kurt R. & Grasdal, Astrid L. & Holmås, Tor Helge, 2006. "Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation?," Working Papers in Economics 14/06, University of Bergen, Department of Economics.
- Kurt R. Brekke & Astrid L. Grasdal & Tor Helge Holmås, 2007. "Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation?," CESifo Working Paper Series 2059, CESifo.
- Herberholz, Chantal & Phuntsho, Sonam, 2021. "Medical, transportation and spiritual out-of-pocket health expenditure on outpatient and inpatient visits in Bhutan," Social Science & Medicine, Elsevier, vol. 273(C).
- Ghislandi, Simone, 2011. "Competition and the Reference Pricing Scheme for pharmaceuticals," Journal of Health Economics, Elsevier, vol. 30(6), pages 1137-1149.
- Danzon Patricia M. & Ketcham Jonathan D., 2004.
"Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand,"
Forum for Health Economics & Policy, De Gruyter, vol. 7(1), pages 1-56, January.
- Patricia M. Danzon & Jonathan D. Ketcham, 2004. "Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand," NBER Chapters, in: Frontiers in Health Policy Research, Volume 7, pages 1-54, National Bureau of Economic Research, Inc.
- Patricia M. Danzon & Jonathan D. Ketcham, 2003. "Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand," NBER Working Papers 10007, National Bureau of Economic Research, Inc.
- Nell, Martin & Richter, Andreas & Schiller, Jörg, 2009.
"When prices hardly matter: Incomplete insurance contracts and markets for repair goods,"
European Economic Review, Elsevier, vol. 53(3), pages 343-354, April.
- Nell, Martin & Richter, Andreas & Schiller, Jörg, 2005. "When prices hardly matter: Incomplete insurance contracts and markets for repair goods," Working Papers on Risk and Insurance 14, University of Hamburg, Institute for Risk and Insurance.
- Nell, Martin & Richter, Andreas & Schiller, Jörg, 2006. "When prices hardly matter: Incomplete insurance contracts and markets for repair goods," Discussion Papers in Business Administration 1187, University of Munich, Munich School of Management.
- Martin Nell & Andreas Richter & Jörg Schiller, 2005. "When prices hardly matter: Incomplete insurance contracts and markets for repair goods," Risk and Insurance 0501002, University Library of Munich, Germany.
- Brekke, Kurt R. & Konigbauer, Ingrid & Straume, Odd Rune, 2007.
"Reference pricing of pharmaceuticals,"
Journal of Health Economics, Elsevier, vol. 26(3), pages 613-642, May.
- Brekke, Kurt R & Königbauer, Ingrid & Straume, Odd Rune, 2005. "Reference Pricing of Pharmaceuticals," Working Papers in Economics 19/05, University of Bergen, Department of Economics.
- Kurt R. Brekke & Ingrid Königbauer & Odd Rune Straume, 2006. "Reference Pricing of Pharmaceuticals," CESifo Working Paper Series 1825, CESifo.
- Eyal Pe’er & Yuval Feldman & Eyal Gamliel & Limor Sahar & Ariel Tikotsky & Nurit Hod & Hilla Schupak, 2019. "Do minorities like nudges? The role of group norms in attitudes towards behavioral policy," Judgment and Decision Making, Society for Judgment and Decision Making, vol. 14(1), pages 40-50, January.
- Carine Franc & Laurent Granier & Sébastien Trinquard, 2013.
"Tarif forfaitaire de responsabilité : quels impacts sur le pharmacien ?,"
Working Papers
1309, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
- Carine Franc & Laurent Granier & Sébastien Trinquard, 2013. "Tarif forfaitaire de responsabilité : quels impacts sur le pharmacien ?," Working Papers halshs-00800457, HAL.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:80:y:2007:i:3:p:459-464. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.
Printed from https://ideas.repec.org/a/eee/hepoli/v80y2007i3p459-464.html